We are live on ! Find out more
BFRI icon

Biofrontera
BFRI

15 hedge funds and large institutions have $3.01M invested in Biofrontera in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

100% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 3

25% more funds holding

Funds holding: 12 → 15 (+3)

13% more capital invested

Capital invested by funds: $2.66M → $3.01M (+$349K)

3.19% more ownership

Funds ownership: 5.3% → 8.49% (+3.2%)

Holders
15
Holders Change
+3
Holders Change %
+25%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
6
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$2.32M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$186K
3
Northern Trust
Northern Trust
Illinois
+$62.9K
4
BA
Bard Associates
Illinois
+$40.1K
5
BlackRock
BlackRock
New York
+$31.1K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$168K
2
Two Sigma Advisers
Two Sigma Advisers
New York
-$60.1K
3
XT
XTX Topco
Cayman Islands
-$48K
4
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$15.2K
5
Citigroup
Citigroup
New York
-$4.55K

BFRI Hedge Fund Activity: Q2 2022 in Review

15 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Biofrontera (BFRI) for Q2 2022, worth a combined $3.01M — up 13% from $2.66M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new BFRI positions and 2 closed out — a net gain of 3 holders — while 6 added to existing stakes and 3 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $2.32M. The largest seller was Citadel Advisors, exiting entirely with an estimated $168K sold.

  • 15 institutional investors held Biofrontera (BFRI) as of Q2 2022, up from 12 in Q1 2022.
  • Funds reported $3.01M of Biofrontera stock for Q2 2022, up 13% quarter-over-quarter.
  • 5 funds opened new Biofrontera positions in Q2 2022 and 2 closed out, a net change of +3 holders.
  • The largest Biofrontera buyer in Q2 2022 was Armistice Capital, an estimated $2.32M added.
  • The largest Biofrontera seller in Q2 2022 was Citadel Advisors, an estimated $168K sold.

Based on aggregated 13F filings for Q2 2022.